Site search
2813 results for '' found
Validation of A Non-Invasive Wearable Technology to Measure Blood Pressure in Cardiac Patients. The VANT- BP study (Trial Not Registered)
Validation of A Non-Invasive Wearable Technology to Measure Blood Pressure in Cardiac Patients. The VANT- BP study (Trial Not Registered)
/
VANTAGE Clinical Trial: (Evaluation of TAVI using the NAVITOR valve in a Global Investigation) (NCT04788888)
VANTAGE Clinical Trial: (Evaluation of TAVI using the NAVITOR valve in a Global Investigation) (NCT04788888)
/
A Phase 3, Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Clinical study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Partici
A Phase 3, Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Clinical study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Partici
/
An open-label, multicenter, outpatient extension study to evaluate the safety and tolerability of Staccato Alprazolam in study participants 12 years of age and older with stereotypical prolonged
An open-label, multicenter, outpatient extension study to evaluate the safety and tolerability of Staccato Alprazolam in study participants 12 years of age and older with stereotypical prolonged
/
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Ol
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Ol
/
A prospective pilot study of the safety and effectiveness of Uterine Artery Embolisation for the treatment of Endometriosis (ACTRN12622001301752)
A prospective pilot study of the safety and effectiveness of Uterine Artery Embolisation for the treatment of Endometriosis (ACTRN12622001301752)
/
Toxicity Reduction with Urethra Sparing radiation Therapy for prostate cancer (ACTRN12625000487415)
Toxicity Reduction with Urethra Sparing radiation Therapy for prostate cancer (ACTRN12625000487415)
/
Evaluation of Outcomes Following Tricuspid Valve Cylinder Reconstruction in Isolated Severe Tricuspid Regurgitation (ACTRN12620000564954p)
Evaluation of Outcomes Following Tricuspid Valve Cylinder Reconstruction in Isolated Severe Tricuspid Regurgitation (ACTRN12620000564954p)
/
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Retatrutide on the Incidence of Major Adverse Cardiovascular Events and the Decline in Kid
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Retatrutide on the Incidence of Major Adverse Cardiovascular Events and the Decline in Kid
/
A Feasibility Trial of Tranexamic Acid for Necrotising Soft-Tissue Infections (ACTRN12621001423808)
A Feasibility Trial of Tranexamic Acid for Necrotising Soft-Tissue Infections (ACTRN12621001423808)
/